Insights

Innovative Oncology Portfolio Shorla Oncology specializes in developing niche cancer treatments, with a recent US product launch of the FDA-approved JYLAMVO oral solution, creating new revenue streams and expanding their market reach in oncology.

Strong Funding Backing The company secured a significant $21 million in recent funding and a $35 million Series B investment from Kurma Partners, demonstrating strong investor confidence that can support international expansion and pipeline development.

Market Expansion Potential With the recent US commercial launch and a growing portfolio of treatment options, Shorla is positioned to increase sales by targeting unmet needs in oncology, especially in markets where treatments are limited or scarce.

Strategic Partnerships Collaborations with commercialization service providers like EVERSANA facilitate market entry and distribution, offering opportunities to expand distribution channels and build relationships with healthcare providers.

Recognition & Leadership Leading awards and leadership appointments enhance company credibility, presenting opportunities to engage with top-tier stakeholders and key opinion leaders in the oncology space for strategic collaborations.

Similar companies to Shorla Oncology

Shorla Oncology Tech Stack

Shorla Oncology uses 8 technology products and services including Salesforce, Google Fonts API, GSAP, and more. Explore Shorla Oncology's tech stack below.

Salesforce
Customer Relationship Management
Google Fonts API
Font Scripts
GSAP
Javascript Frameworks
PHP
Programming Languages
MonsterInsights
Web Platform Extensions
GeneratePress GP Premium
Web Platform Extensions
Apache
Web Servers
Nginx
Web Servers

Media & News

Shorla Oncology's Email Address Formats

Shorla Oncology uses at least 1 format(s):

Shorla Oncology Email Formats	Example	Percentage
First.Last@shorlaoncology.com	John.Doe@shorlaoncology.com	48%
Last.F@shorlaoncology.com	Doe.J@shorlaoncology.com	2%
First.Last@shorlaoncology.com	John.Doe@shorlaoncology.com	48%
Last.F@shorlaoncology.com	Doe.J@shorlaoncology.com	2%

Frequently Asked Questions

Where is Shorla Oncology's headquarters located?

Shorla Oncology's main headquarters is located at Clonmel, Tipperary e91 v239 Ireland. The company has employees across 2 continents, including EuropeNorth America.

What is Shorla Oncology's official website and social media links?

Shorla Oncology's official website is shorlaoncology.com and has social profiles on LinkedIn.

What is Shorla Oncology's NAICS code?

Shorla Oncology's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Shorla Oncology have currently?

As of February 2026, Shorla Oncology has approximately 42 employees across 2 continents, including EuropeNorth America. Key team members include Ceo & Co-Founder: S. C.Chief Technical Officer: O. R.Vp Of Quality And Regulatory; Responsible Person: V. M.. Explore Shorla Oncology's employee directory with LeadIQ.

What industry does Shorla Oncology belong to?

Shorla Oncology operates in the Pharmaceutical Manufacturing industry.

What technology does Shorla Oncology use?

Shorla Oncology's tech stack includes SalesforceGoogle Fonts APIGSAPPHPMonsterInsightsGeneratePress GP PremiumApacheNginx.

What is Shorla Oncology's email format?

Shorla Oncology's email format typically follows the pattern of First.Last@shorlaoncology.com. Find more Shorla Oncology email formats with LeadIQ.

When was Shorla Oncology founded?

Shorla Oncology was founded in 2018.

Shorla Oncology

Q: What is Shorla Oncology's official website and social media links?

Shorla Oncology's official website is shorlaoncology.com. Shorla Oncology has social profiles on LinkedIn.

Q: How many employees does Shorla Oncology have currently?

Shorla Oncology has approximately 42 employees.

Q: What technology does Shorla Oncology use?

Shorla Oncology's tech stack includes Apache, Microsoft 365, RSS, Google Analytics, MySQL.

Pharmaceutical ManufacturingTipperary, Ireland11-50 Employees

At Shorla Oncology we develop and commercialize innovative oncology drugs. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population.

Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments.

Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.